| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 7 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 7 |
| 2 | TACROLIMUS OINTMENT 0.1% | 7 |
| 3 | FOLIC ACID | 5 |
| 4 | LEVETIRACETAM | 5 |
| 5 | LEVETIRACETAM IN SODIUM CHLORIDE | 4 |
| 6 | LEVETIRACETAM INJECTION | 4 |
| 7 | LEVETIRACETAM ORAL | 4 |
| 8 | VALACYCLOVIR | 4 |
| 9 | VALACYCLOVIR HYDROCHLORIDE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN RHO(D) IMMUNE GLOBULIN | 2 | 0.0019 |
| 1 | METHYLERGONOVINE MALEATE | 1 | 0.0016 |
| 2 | BUPRENORPHINE HCL | 1 | 0.0011 |
| 3 | PYRIMETHAMINE | 1 | 0.0008 |
| 4 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 5 | DOPAMINE HYDROCHLORIDE | 1 | 0.0003 |
| 6 | VALPROATE SODIUM | 4 | 0.0002 |
| 7 | OFLOXACIN OTIC SOLUTION | 1 | 0.0001 |
| 8 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 1 | 0.0001 |
| 9 | OFLOXACIN OTIC | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 1 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 2 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 3 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 4 | Progesterone [EPC] | 2 | 0.0001 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 7 | Polyene Antifungal [EPC] | 2 | 0.0000 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Protease Inhibitor [EPC] | 1 | 0.0000 |